Seaprose S shortage status
1 active shortage notice across 1 country.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Seaprose S
- Brand names
- Anpin, Korynase E.C
- Class
- Auto-created by TFDA — Drug Supply Information Platform (Taiwan) scraper
Where Seaprose S is in shortage
Why Seaprose S is in shortage
- raw-material (API) supply problems — e.g. “杏林新生製藥股份有限公司表示，因原物料問題，目前控貨中，無法預計恢復正常供應時程。” (Taiwan)
Frequently asked questions
Is Seaprose S currently in shortage?
Yes. As of the latest regulator updates, Seaprose S has 1 active shortage notice across 1 country (Taiwan). Status is refreshed daily from official regulatory sources.
Why is Seaprose S in shortage?
Regulators attribute the current Seaprose S shortages to raw-material (API) supply problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Seaprose S shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Seaprose S status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.